Generics increase competition: study

Share this article:
A new study funded by PhRMA says the increasing use of authorized generics by drug companies has not led to delays in generic entry into the marketplace. “This study and others show that authorized generics are increasing competition and helping lower prescription drug prices for patients, not harming competition,” said PhRMA VP, policy and research, Lori Reilly. “As a result, proposals to restrict authorized generics would reduce consumer savings.”

The study by an MIT professor and Analysis Group researchers reportedly confirmed that the  increase in generics had not reduced incentives to challenge brand name patents.

Share this article:

Email Newsletters

More in News

BMS Q2 sales slip, Eliquis, Yervoy soar

BMS Q2 sales slip, Eliquis, Yervoy soar

The company attributed part of the Eliquis boost to the BMS-Pfizer DTC and education efforts.

Gilead, Merck HCV marketing battle may be on horizon

Gilead, Merck HCV marketing battle may be on ...

Disclosed in its earnings report yesterday, Gilead may have a card up its sleeve to counter Merck's experimental hep. C combo regimen.

Sales of Biogen MS pill pick up overseas

Sales of Biogen MS pill pick up overseas

Biogen Idec is seeing strong sales for blockbuster MS drug Tecfidera, especially overseas where it's beginning to catch fire this summer.